Stock screenerAll disclosures →
EDGAR →
CDT
Conviction 22HealthcareScan · Mon, Jul 20, 2026Bullish marubozu
CDT$3.57+1039.12%
ResistanceSupportVol 14Vol MA14 407.48K
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price3.57
Change+1039.12%
Gap+914.68%
Rel volume0.00×
Avg volume6.62M
Avg $ vol9.27M
SMA 200.7338
SMA 500.9861
SMA 2001.74
Price vs 50+262.03%
Price vs 200+105.01%
MA stackmixed
50/200 cross—
Supertrendup · 2.08
RSI (14)85
MACD hist0.22
MACD crossbull · 5d
Stoch %K / %D100 / 39
ADX (14)18
+DI / −DI72 / 10
RSI divergenceBullish
MACD divergenceBullish
ATR %+10.48%
ADR %18.65%
52w high9.35
52w low0.3134
From 52w high-61.82%
Above 52w low+1039.12%
New 52w highNo
SqueezeOff
Bollinger width391.76%
%B1.49
Donchian pos100.00%
Donchian high3.57
Donchian low0.3000
AVWAP (52w high)1.38
vs AVWAP high+159.47%
AVWAP (52w low)0.4386
vs AVWAP low+713.99%
OBV trendUp
Chaikin MF (20)-0.31
Today vs 20d0.00×
Avg vol (14d)407.48K
Avg vol (20d)6.62M
Avg $ vol (20d)9.27M
Market cap22.53M
RS 3m (vs SPY)-97.05%
RS 6m (vs SPY)-85.28%
RS line new highNo
Trend template3/8
Technical rank98.4
1 week+895.54%
1 month+415.15%
3 months+3.18%
6 months+164.44%
1 year+60.09%
YTD+147.92%
P/E-0.57
P/B0.21
P/S—
P/FCF-1.44
EPS-1,177.89
Div yield—
ROE-37.20%
ROA-30.86%
Debt/Eq—
Current0.14
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-120.33%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value22.43M
Revenue—
Net income-4.06M
Gross profit—
Free cash flow-15.61M
IndustryPharmaceutical Preparations
ExchangeNasdaq
Shares out4.86M
Employees4
ListedMon, Sep 25, 2023
Free float1.1M
Float %22.7%
Short interest167.69K
Days to cover0.0d
Short volume49.8%
Squeeze score37 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction22 / 100
Pattern quality—
Tech rank98.4 / 100
Group rank—
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish marubozu
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CDT
No recent disclosed trades by Congress in CDT. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CDT · 2 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Regan Andrew Chief Executive Officer · Common Stock · 2026-05-13 | Grant | 100K | $190K | 2026-05-13 | 2026-05-14 |
Regan Andrew Chief Executive Officer · Common Stock · 2026-03-24 | Grant | 147.4K | — | 2026-03-24 | 2026-05-14 |
Regan Andrew Chief Executive Officer · Pre-Funded Warrants · 2026-03-24 | Convert | 147.4K | $15 | 2026-03-24 | 2026-05-14 |
Regan Andrew Chief Executive Officer · Common Stock · 2026-03-24 | Other | — | — | 2026-03-24 | 2026-05-14 |
SEC filings
EDGAR filings in CDT · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.